| Literature DB >> 35311136 |
Xianwen Zou1, Guiqi Ma1, Pengyu Zhu1, Yutao Cao1, Xiao Sun1, Haijun Wang2, Jian Dong1.
Abstract
In this work, Arg-Gly-Asp (RGD) peptide-coupled polydopamine-modified mesoporous platinum nanoparticles (mPt@PDA-RGD NPs) were developed for targeted photothermal therapy (PTT) and migration inhibition of SKOV-3 cells. mPt@PDA-RGD NPs with obvious core/shell structure demonstrated high photothermal performance under 808-nm near-infrared (NIR) laser irradiation. mPt@PDA-RGD NPs with favorable biocompatibility exhibited remarkable SKOV-3 inhibition ability under NIR laser irradiation. Moreover, compared to mPt@PDA NPs, the RGD-functionalized NPs achieved more tumor uptake and PTT performance, which was attributed to the specific interaction between RGD of NPs and αvβ3 integrin overexpressed by SKOV-3. Importantly, cell scratch experiments indicated that the photothermal effect of mPt@PDA-RGD NPs can effectively inhibit the migration of surviving SKOV-3 cells, which was assigned to disturbance of the actin cytoskeleton of SKOV-3. Thus, mPt@PDA-RGD NPs presented great potential for targeted tumor photothermal ablation and migration inhibition.Entities:
Keywords: PTT; RGD target; migration inhibition; photothermal ablation; platinum nanoplatform
Year: 2022 PMID: 35311136 PMCID: PMC8929664 DOI: 10.3389/fonc.2022.860718
Source DB: PubMed Journal: Front Oncol ISSN: 2234-943X Impact factor: 6.244
Scheme 1The synthesis of Arg-Gly-Asp peptide-coupled polydopamine-modified mesoporous platinum nanoparticles (mPt@PDA-RGD NPs) and their application in targeted cancer therapy.
Figure 1Transmission Electron Microscope (TEM) images of mPt NPs (A, B). Pore size distribution (C) and X-ray diffraction (XRD) patterns (D) of mPt NPs. (E) TEM image of mPt@PDA NPs. X-ray photoelectron spectroscopy (XPS) spectra (F) of mPt@PDA NPs. (G) Fourier transform infrared spectroscopy (FTIR) of mPt@PDA NPs and mPt@PDA-RGD NPs. Size distribution (H) and Zeta potential (I) of mPt NPs, mPt@PDA NPs, and mPt@PDA-RGD NPs. (J) Uv-visible absorption spectrum (UV-Vis) spectral of mPt NPs and mPt@PDA-RGD NPs.
Figure 2(A) Temperature responses of mPt@PDA-RGD NP solutions with various Pt concentrations under the 808-nm laser. (B) Temperature responses of mPt@PDA-RGD NP solutions (100 μg/ml) under the 808-nm laser with different power densities for 300 s. (C) The heating curve of the mPt@PDA-RGD NP dispersion in deionized water at 4 laser on/off cycles (1.5 W/cm2) under 808-nm laser irradiation.
Figure 3Cytotoxicity of (A) mPt NPs and (B) mPt@PDA-RGD NPs. (C) Relative viability of SKOV-3 cells treated with mPt@PDA-RGD NPs and laser. (D) Pt contents in SKOV-3 cells with different treatments. All values are presented as means ± standard errors of the mean (SEM); *p < 0.05. (E) Flow cytometry analysis of SKOV-3 cells. (F) Calcein AM/PI staining of SKOV-3 cells with various treatments: (a) control, (b) laser (808 nm), (c) mPt@PDA-RGD NPs, (d) mPt@PDA-RGD NPs+laser.
Figure 4(A) Immunofluorescence images and (B) Western blot analysis of SKOV-3 actin staining after various treatments. (C) Corresponding migration rate. All values are presented as means ± standard errors of the mean (SEM); ****p < 0.0001, ***p < 0.001. (D) The migration performance of SKOV-3 cells with various treatments.